Clinical Trials

Leicester is an internationally recognised leading Centre for clinical trials in mesothelioma, exploring novel therapies from phase I through to phase III. Our portfolio of clinical studies encompass early disease involving surgery, to advanced treatment in refractory disease.

Industry Trials

1st Line
ATOMIC

 

Investigator Led Studies

Surgery                                       
Mars2

Relapsed Mesothelioma
VIM
CONFIRM
FAK-PD1
MiST